Reflections from MedTech Conference 2025

AI is no longer on the sidelines of healthcare. It is officially mainstream.

At this year’s MedTech Conference in San Diego, artificial intelligence took center stage. Nearly every keynote and workshop explored how AI can streamline change management, improve documentation, and strengthen supply chains across life sciences. Yet even with all the excitement, many conversations still described AI as a supporting player, a helpful tool that enhances existing processes rather than reimagines them.

At OmicXHealth, we see AI differently. Our cfDNA methylation-based platform uses AI and machine learning not just to assist research but to drive it. By moving discovery and validation from the wet lab to the computational core, we are redefining how innovation happens. For us, AI is not a background tool. It is the engine of discovery.

Beyond the main sessions, the energy in San Diego reflected a field on the verge of transformation. The MedTech Innovator showcase and Pitch and Pour competition highlighted the creativity and persistence shaping the next generation of healthcare solutions. The conversations around early-stage funding and clinical translation also offered valuable insight into how collaboration and adaptability can turn ideas into real-world impact.

The week reached a high point with a keynote from Arnold Schwarzenegger and Ivan Tornos, whose message was clear: the future of health depends on courage, conviction, and the willingness to think differently. Their words deeply align with our mission.

At OmicXHealth, we are proud to be part of this movement, pushing the boundaries of precision diagnostics and showing that the next frontier of medicine is not just in vitro—it is in silico.